
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6615914
[patent_doc_number] => 20100003221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Medium Supplement for Virus Production'
[patent_app_type] => utility
[patent_app_number] => 12/444248
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6857
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003221.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444248
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444248 | Medium supplement for virus production | Oct 10, 2007 | Issued |
Array
(
[id] => 4833913
[patent_doc_number] => 20080132460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'ROLE OF p62 IN AGING-RELATED DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/871146
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 26296
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11871146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/871146 | ROLE OF p62 IN AGING-RELATED DISEASE | Oct 10, 2007 | Abandoned |
Array
(
[id] => 6313903
[patent_doc_number] => 20100111897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Methods and Compositions Useful for Diabetic Wound Healing'
[patent_app_type] => utility
[patent_app_number] => 12/444412
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22821
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111897.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444412 | Methods and compositions useful for diabetic wound healing | Oct 4, 2007 | Issued |
Array
(
[id] => 6585111
[patent_doc_number] => 20100047842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'NOVEL TOXICITY ASSAY BASED ON HUMAN BLASTOCYST-DERIVED STEM CELLS AND PROGENITOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/444017
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8497
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444017 | Toxicity assay based on human blastocyst-derived stem cells and progenitor cells | Oct 1, 2007 | Issued |
Array
(
[id] => 4833877
[patent_doc_number] => 20080132424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 11/906535
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8613
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132424.pdf
[firstpage_image] =>[orig_patent_app_number] => 11906535
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/906535 | Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells | Oct 1, 2007 | Abandoned |
Array
(
[id] => 5336746
[patent_doc_number] => 20090053210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals'
[patent_app_type] => utility
[patent_app_number] => 11/895910
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10779
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11895910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/895910 | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals | Aug 26, 2007 | Abandoned |
Array
(
[id] => 4644277
[patent_doc_number] => 08021882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith'
[patent_app_type] => utility
[patent_app_number] => 11/844941
[patent_app_country] => US
[patent_app_date] => 2007-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 26
[patent_no_of_words] => 11628
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/021/08021882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11844941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/844941 | Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith | Aug 23, 2007 | Issued |
Array
(
[id] => 4651096
[patent_doc_number] => 20080038352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Electroprocessed Collagen and Tissue Engineering'
[patent_app_type] => utility
[patent_app_number] => 11/842748
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 52496
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842748 | Electroprocessed Collagen and Tissue Engineering | Aug 20, 2007 | Abandoned |
Array
(
[id] => 92199
[patent_doc_number] => 07732400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury'
[patent_app_type] => utility
[patent_app_number] => 11/894809
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7816
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732400.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894809 | Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury | Aug 19, 2007 | Issued |
Array
(
[id] => 5415838
[patent_doc_number] => 20090041725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Replication-Deficient RNA Viruses as Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/836322
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13693
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11836322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/836322 | Replication-Deficient RNA Viruses as Vaccines | Aug 8, 2007 | Abandoned |
Array
(
[id] => 4650949
[patent_doc_number] => 20080038205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'NOVEL DERMATOPHAGOIDES PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/836317
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 36553
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038205.pdf
[firstpage_image] =>[orig_patent_app_number] => 11836317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/836317 | NOVEL DERMATOPHAGOIDES PROTEINS | Aug 8, 2007 | Abandoned |
Array
(
[id] => 4577510
[patent_doc_number] => 07833789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-16
[patent_title] => 'Monocyte cell'
[patent_app_type] => utility
[patent_app_number] => 11/831248
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 42
[patent_no_of_words] => 18800
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/833/07833789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11831248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/831248 | Monocyte cell | Jul 30, 2007 | Issued |
Array
(
[id] => 5523453
[patent_doc_number] => 20090031434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'ANIMAL MODELS FOR OBESITY AND NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/828832
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12658
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20090031434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11828832
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/828832 | ANIMAL MODELS FOR OBESITY AND NEURODEGENERATIVE DISEASES | Jul 25, 2007 | Abandoned |
Array
(
[id] => 167249
[patent_doc_number] => 07666423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/829070
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 18
[patent_no_of_words] => 21362
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666423.pdf
[firstpage_image] =>[orig_patent_app_number] => 11829070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/829070 | Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells | Jul 25, 2007 | Issued |
Array
(
[id] => 6248711
[patent_doc_number] => 20100137202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'COMPOSITIONS FOR REPROGRAMMING A CELL AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/374018
[patent_app_country] => US
[patent_app_date] => 2007-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 28521
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374018 | COMPOSITIONS FOR REPROGRAMMING A CELL AND USES THEREFOR | Jul 18, 2007 | Abandoned |
Array
(
[id] => 4478899
[patent_doc_number] => 07906701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'p300 transgenic animal'
[patent_app_type] => utility
[patent_app_number] => 11/827438
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 4483
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906701.pdf
[firstpage_image] =>[orig_patent_app_number] => 11827438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/827438 | p300 transgenic animal | Jul 10, 2007 | Issued |
Array
(
[id] => 4932437
[patent_doc_number] => 20080003212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor'
[patent_app_type] => utility
[patent_app_number] => 11/562699
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9597
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11562699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/562699 | ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor | Jul 9, 2007 | Abandoned |
Array
(
[id] => 7680761
[patent_doc_number] => 20100024047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Prion-free transgenic ungulates'
[patent_app_type] => utility
[patent_app_number] => 11/827103
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17613
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20100024047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11827103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/827103 | Prion-free transgenic ungulates | Jul 8, 2007 | Abandoned |
Array
(
[id] => 5479483
[patent_doc_number] => 20090202440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'MODEL ANIMAL OF DENDRITIC CELL IMMUNORECEPTOR GENE KNOCKOUT DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/306220
[patent_app_country] => US
[patent_app_date] => 2007-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9096
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12306220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/306220 | MODEL ANIMAL OF DENDRITIC CELL IMMUNORECEPTOR GENE KNOCKOUT DISEASE | Jun 25, 2007 | Abandoned |
Array
(
[id] => 5373662
[patent_doc_number] => 20090311223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'TREATMENT OF ERECTILE DYSFUNCTION BY STEM CELL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/305589
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22753
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311223.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305589 | Treatment of erectile dysfunction by stem cell therapy | Jun 21, 2007 | Issued |